StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3089% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Specified Item: Intangible Asset Amortization by Year

Specified Item: Intangible Asset Amortization — Pre-Tax ($M) ($M)

AbbVie Specified Item: Intangible Asset Amortization: $7,377M in FY2025, down 3.2% from a year earlier.

Latest, FY2025
7,377
Period ended Dec 31, 2025
Change on a year earlier
-3.2%
7,622 in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below

Where the FY2025 figure comes from

“|| Intangible asset amortization | 7,377 | 6,221 | 3.50”

Source: Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗

Reported in Form 8-K Non-GAAP Reconciliations.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecified Item: Intangible Asset Amortization — Pre-Tax ($M) ($M)Year on yearSource
FY2025Dec 31, 20257,377-3.2%Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
FY2024Dec 31, 20247,622-4.1%Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗
FY2023Dec 31, 20237,946+3.3%Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
FY2022Dec 31, 20227,689–Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗

Breakdown

What makes up specified Item: Intangible Asset Amortization

Cite this data

StockData. (2026). AbbVie Specified Item: Intangible Asset Amortization ($M), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap-spec-amort-pretax

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.